Analyst Ratings for Royalty Pharma (RPRX)

RPRX Rating Summary

RPRX Price Target Summary

* Over Last 12-Mos
  |   Expand Research on RPRX
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: $49.68 (+18%) * Over Last 12-Mos
Rating Score: 7.5 / 10   Percentile Rank: 76%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
6/14/2022 UBS Ashwani Verma New Coverage Buy
(N/A)		 47.00
(N/A)		 40.48
(42.09)		 3.98% Details
5/13/2022 Scotiabank Adam Buckham New Coverage Sector Outperform
(N/A)		 53.00
(N/A)		 38.95
(42.09)		 8.06% Details
Like RPRX Ratings? Also take a look at BPMC, CYTK, BCRX, FGEN

RPRX Ratings News